18.97.14.90
dgid:
enl:
npi:0
/nas/content/live/oph360live/wp-content/themes/rd360/archive.php
-Advertisement-

Retina Care 360

Real-world data highlights faricimab’s effectiveness in patients with treatment-experienced nAMD

Faricimab provides significant anatomical improvements and extends treatment intervals in treatment-experienced patients with neovascular age-related macular degeneration (nAMD), while maintaining vision and potentially reducing the treatment burden, according to results from a real-world study. The single-center retrospective study included 184 patients (215 eyes) who switched to faricimab after receiving an...

Read More
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-